Cardiovascular disease and menopause

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 2, 2014, Pages 62-64

  Dosi, Rupal ^a   Bhatt, Nikita ^a   Shah, Priyanki ^a   Patell, Rushad ^a  

^a Department of Medicine Medical College Baroda   (India)

Author keywords

Coronary artery disease; Estrogen; Menopause

Indexed keywords

CHOLESTEROL; CREATININE; ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD CELL COUNT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MENOPAUSE; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; THORAX RADIOGRAPHY; UREA BLOOD LEVEL; URINALYSIS; WAIST HIP RATIO;

EID: 84893461717     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/6457.4009     Document Type: Article

References (29)

1. K. Srinath Reddy, Salim Yusuf. Emerging Epidemic of Cardiovascular Disease in Developing Countries. Circulation.1998; 97: 596-601.
2. Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol. 2012 Oct 2;60(14):1207-16.
3. Sybil L. Crawford and Catherine B. Johanner: The epidemiology of cardiovascular disease in postmenopausal women. Clinical Endocr. And Metabol. 1999;:1803-06.
4. Debra F. Skafar, RuiXu, Juan Morales, Jeffrey Ram and James R. Sowers: Female sex hormones and cardiovascular disease in women. Journal of Clin. Endocr. Metabol. 1997, 82 (12); 3913-18.
5. Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. Journal of Clin Endocr. Metabolism. 1997;82:3955-63.
6. Mendelsohn ME, Karas RH. The protective effects of estrogen on cardiovascular system. New England Journal of Medicine. June 1999. (340): 1801-11.
7. Trémollières FA, Pouilles JM, Cauneille C, Ribot C. Coronary Heart Disease risk factors and menopause: a study in 1684 French women. Atherosclerosis. (1999) 142 (2); 415-23
8. Jouyandeh Z, Nayebzadeh F, Qorbani M, Asadi M. Metabolic syndrome and menopause. J Diabetes Metab Disord. 2013, Jan 3;12(1).
9. Marjani A, Moghasemi S. The Metabolic Syndrome among PostmenopausalWomen in Gorgan. Int J Endocrinol. 2012;2012:953627.
10. sted. New Delhi: South Asian Society on Atherosclerosis and Thrombosis; 2007.
11. Misra A, Khurana L. The metabolic syndrome in South Asians: Epidemiology, clinical correlates and possible solutions. International Diabetes Monitor 2009;21:92-101.
12. Bagga A. Age and symptomatology of Menopause: A case study. Obstet Gynaecol Today. 2004;10:660-6.
13. M Singh. Early age of natural menopause in India, a biological marker for early preventive health programs. Climacteric, December 2012;15 (6): 581-86.
14. Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B. Cigarette smoking, relative weight and menopause, Am J Epidemiology 117:651, 1983.
15. Effects of estrogen or estrogen/progestin regiments on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI). Trial the writing group for PEPI trial. JAMA. 1995; 273:199.
16. Papadopoulou SA, Kaski JC. Ischemic heart Disease in the Aging Woman. Best Practice & Research Clinical Obstetrics &Gynaecology. 25 March 2013
17. Roger VL, Jacobsen SJ, Pellikka PA, Miller TD, Bailey KR, Gersh BJ.: Gender differences in use of stress lasting and coronary disease mortality: A population based study in Olmsted country, Minnesota.J. Am. Coll. Cardiol.1998;32:345.
18. Yamamoto A, Horibe H, Mabuchi H, Kita T, Matsuzawa Y, Saito Y, et al. Analysis of Serum lipid levels in Japanese men and women according to B.M. I Increase in risk of atherosclerosis in postmenopausal women. Research group on serum survey. Atherosclerosis. 1999 May; 143 (1):55-73.
19. Tchernof A, Calles-Escandon J, Sites CK, PoehlmanET. Menopause, central body fatness and insulin resistance. Effects of hormone replacement therapy. Coronary A disease 1998;9(8): 503-11.
20. Florence A. Tremollieres et al: Coronary Heart Disease risk factors and menopause: a study in 1684 French women. Atherosclerosis. (1999);142(2): 415-23.
21. Perry AC. et al.: Relation between anthropometric measures of fat distribution and cardiovascular risk factors in overweight pre and post-menopausal women. American J Clin. Nutr. 1997 Oct; 66(4): 829-35.
22. Matthews KA. et al.: changes in cardiovascular risk factors during premenopausal and postmenopausal and carotid artery atherosclerosis in healthy women. Stroke.2001 may; 32(5): 1104-11.
23. Gambacciani M; et al. The effect of menopause on blood lipid and lipoprotein levels the Icarus study group. Atherosclerosis 1999 nov. 1; 147(1): 147-53.
24. th ed. Vol. 2. New York: McGraw Hill, 2012. 3040-45.
25. De Ziegler D.: Cardiovascular physiology of ovarian hormones, SchweizRundsch Med. 1997. Jan. 28; 86 (5): 138-44.
26. Taylor HS, Manson JE. Update in hormone therapy use in menopause. J Clin Endocrinol Metab 2011; 96:255.
27. Main C, Knight B, Moxham T, Gabriel Sanchez R, Sanchez Gomez LM, Roqué I, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2013 Apr 30;4.
28. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288:321.
29. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409